History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium
- PMID: 22144496
- PMCID: PMC3275674
- DOI: 10.1158/1055-9965.EPI-11-0590
History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium
Abstract
Background: A history of diabetes is associated with an increased risk of several types of cancers. Whether diabetes is a risk factor for head and neck cancer (HNC) has received little attention.
Methods: We pooled data from 12 case-control studies including 6,448 cases and 13,747 controls, and estimated OR and 95% CI for the associations between diabetes and HNC, adjusted for age, education level, sex, race/ethnicity, study center, cigarette smoking, alcohol use, and body mass index.
Results: We observed a weak association between diabetes and the incidence of HNC overall (OR, 1.09; 95% CI: 0.95-1.24). However, we observed a modest association among never smokers (OR, 1.59; 95% CI: 1.22-2.07), and no association among ever smokers (OR, 0.96; 95% CI: 0.83-1.11); likelihood ratio test for interaction P = 0.001.
Conclusion: A history of diabetes was weakly associated with HNC overall, but we observed evidence of effect modification by smoking status, with a positive association among those who never smoked cigarettes.
Impact: This study suggests that glucose metabolism abnormalities may be a HNC risk factor in subgroups of the population. Prospective studies incorporating biomarkers are needed to improve our understanding of the relationship between diabetes and HNC risk, possibly providing new strategies in the prevention of HNC.
©2011 AACR.
Conflict of interest statement
CONFLICTS OF INTEREST: No potential conflicts of interest.
Figures


References
-
- Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA. 2000;283:2552–8. - PubMed
-
- Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, et al. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study. Diabetes Care. 2003;26:1752–8. - PubMed
-
- Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293:194–202. - PubMed
-
- Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B, et al. Prospective study of hyperglycemia and cancer risk. Diabetes Care. 2007;30:561–7. - PubMed
Publication types
MeSH terms
Grants and funding
- P01 CA068384/CA/NCI NIH HHS/United States
- T32CA009142/CA/NCI NIH HHS/United States
- R01 DA011386/DA/NIDA NIH HHS/United States
- R01 CA030022/CA/NCI NIH HHS/United States
- K07 CA104231/CA/NCI NIH HHS/United States
- R01DE013158/DE/NIDCR NIH HHS/United States
- R03CA113157/CA/NCI NIH HHS/United States
- R03 CA113157/CA/NCI NIH HHS/United States
- P50 CA090388/CA/NCI NIH HHS/United States
- P30 ES010126/ES/NIEHS NIH HHS/United States
- P50CA090388/CA/NCI NIH HHS/United States
- R01DE012609/DE/NIDCR NIH HHS/United States
- R01CA030022/CA/NCI NIH HHS/United States
- P30 CA015704/CA/NCI NIH HHS/United States
- R01 DE013158/DE/NIDCR NIH HHS/United States
- P01CA068384/CA/NCI NIH HHS/United States
- R21ES011667/ES/NIEHS NIH HHS/United States
- T32 CA009142/CA/NCI NIH HHS/United States
- U01 CA096134/CA/NCI NIH HHS/United States
- R03 CA077954/CA/NCI NIH HHS/United States
- R21 ES011667/ES/NIEHS NIH HHS/United States
- R01DA011386/DA/NIDA NIH HHS/United States
- R01CA048896/CA/NCI NIH HHS/United States
- U01CA096134/CA/NCI NIH HHS/United States
- K07CA104231/CA/NCI NIH HHS/United States
- P30ES010126/ES/NIEHS NIH HHS/United States
- R03CA077954/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical